Cargando…
Intravenous immunoglobulin and Alzheimer’s disease: what now?
Intravenous immunoglobulin (IVIG) products are prepared from purified plasma immunoglobulins from large numbers of healthy donors. Pilot studies with the IVIG preparations Octagam and Gammagard in individuals with mild-to-moderate Alzheimer’s disease (AD) suggested stabilization of cognitive functio...
Autor principal: | Loeffler, David A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720252/ https://www.ncbi.nlm.nih.gov/pubmed/23735288 http://dx.doi.org/10.1186/1742-2094-10-70 |
Ejemplares similares
-
Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?
por: Loeffler, David A
Publicado: (2014) -
Erratum: Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?
por: Loeffler, David A
Publicado: (2015) -
Alzheimers Disease: Review of Emerging Treatment Role for Intravenous Immunoglobulins
por: Kayed, Rakez, et al.
Publicado: (2011) -
Intravenous immunoglobulin for the treatment of Alzheimer’s disease: current evidence and considerations
por: Schindowski, Christina, et al.
Publicado: (2014) -
Emerging diseases--what now?
por: Alleyne, G A
Publicado: (1998)